NN is trading at $3.69, down 5.63%, with no confirmed fresh catalyst.

  • A recent $50 million private placement involving common shares and pre-funded warrants may pose a supply overhang, but available sources do not establish it caused the decline.
  • The preferred-stock redemption was announced October 8. Details of the October 13 registration filing were unavailable, and neither confirms the reason for the decline.